Your browser doesn't support javascript.
loading
Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.
Jodai, Takayuki; Saruwatari, Koichi; Ikeda, Tokunori; Moriyama, Eiji; Kashiwabara, Kosuke; Shingu, Naoki; Iyonaga, Kazuhiro; Inaba, Megumi; Ajishi, Yusuke; Honda, Chiharu; Hirosako, Susumu; Maruyama, Hirotaka; Kakiuchi, Yosuke; Eida, Hirofumi; Tomita, Yusuke; Saeki, Sho; Ichiyasu, Hidenori; Sakagami, Takuro.
Afiliación
  • Jodai T; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Saruwatari K; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan. ksaruwat@kuh.kumamoto-u.ac.jp.
  • Ikeda T; Department of Clinical Investigation, Kumamoto University Hospital, Kumamoto, Japan.
  • Moriyama E; Department of Medical Oncology, Miyazaki Higashi Hospital, Miyazaki, Japan.
  • Kashiwabara K; Department of Respiratory Medicine, Kumamoto Regional Medical Center, Kumamoto, Japan.
  • Shingu N; Department of Respiratory Medicine, Saiseikai Kumamoto Hospital, Kumamoto, Japan.
  • Iyonaga K; Department of Respiratory Medicine, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Inaba M; Department of Respiratory Medicine, Kumamoto Chuo Hospital, Kumamoto, Japan.
  • Ajishi Y; Department of Respiratory Medicine, Miyazaki Prefectural Nobeoka Hospital, Nobeoka, Japan.
  • Honda C; Department of Respiratory Medicine, Tamana Central Hospital, Tamana, Japan.
  • Hirosako S; Department of Respiratory Medicine, Omuta Tenryo Hospital, Omuta, Japan.
  • Maruyama H; Department of Respiratory Medicine, Japan Organization of Occupational Health and Safety, Kumamoto Rosai Hospital, Yatushiro, Japan.
  • Kakiuchi Y; Department of Respiratory Medicine, National Hospital Organization Kumamoto Saishun Medical Center, Koshi, Japan.
  • Eida H; Department of Respiratory Medicine, Minamata City General Hospital and Medical Center, Minamata, Japan.
  • Tomita Y; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Saeki S; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Ichiyasu H; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Sakagami T; Department of Respiratory Medicine, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Int J Clin Oncol ; 26(1): 78-86, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32965577
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón